LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Thermo Fisher Scientific Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$261.41M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-6.64%
quarter
Thermo Fisher Scientific Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.54% | 7.79K shares | -14.36M | $507.19 | 515.41K |
Q2 2022 | share | Increase | +1.34% | 6.69K shares | -20.09M | $543.28 | 507.62K |
Q1 2022 | share | Increase | +0.93% | 4.61K shares | -35.28M | $590.65 | 500.92K |
Q4 2021 | share | Increase | +3.30% | 15.85K shares | 56.66M | $665.45 | 496.31K |
Q3 2021 | share | Increase | +14.35% | 60.28K shares | 62.53M | $571.33 | 480.45K |
Q2 2021 | share | Increase | +22.05% | 75.91K shares | 54.85M | $504.24 | 420.16K |
Q1 2021 | share | Increase | +40.88% | 99.89K shares | 43.29M | $455.92 | 344.25K |
Q4 2020 | share | Increase | +10.09% | 22.39K shares | 15.81M | $465.04 | 244.35K |
Q3 2020 | share | Increase | +0.69% | 1.51K shares | 18.12M | $440.61 | 221.95K |
Q2 2020 | share | Decrease | -0.54% | -1.20K shares | 17.01M | $361.41 | 220.43K |
Q1 2020 | share | Decrease | -0.12% | -260 shares | -9.23M | $282.69 | 221.63K |
Q4 2019 | share | Decrease | -0.02% | -51 shares | 7.44M | $323.59 | 221.89K |
Q3 2019 | share | Increase | +1.07% | 2.34K shares | 152K | $289.95 | 221.95K |
Q2 2019 | share | Increase | +0.38% | 824 shares | 4.60M | $292.16 | 219.60K |
Q1 2019 | share | Decrease | -0.35% | -776 shares | 10.75M | $272.12 | 218.78K |
Q4 2018 | share | Increase | +4.27% | 8.99K shares | -2.25M | $222.32 | 219.56K |
Q3 2018 | share | Increase | +4.85% | 9.73K shares | 9.79M | $242.31 | 210.56K |
Q2 2018 | share | Increase | +2.57% | 5.03K shares | 1.17M | $205.49 | 200.82K |
Q1 2018 | share | Increase | +1.93% | 3.70K shares | 3.94M | $204.65 | 195.78K |
Q4 2017 | share | Increase | +1.35% | 2.55K shares | 614K | $188.07 | 192.08K |
Q3 2017 | share | Increase | +1.58% | 2.94K shares | 3.10M | $187.25 | 189.52K |
Q2 2017 | share | Increase | +6.03% | 10.61K shares | 5.72M | $172.53 | 186.58K |
Q1 2017 | share | Increase | +0.71% | 1.24K shares | 2.37M | $151.77 | 175.97K |
Q4 2016 | share | Increase | +31.65% | 42.00K shares | 3.54M | $139.28 | 174.72K |
Q3 2016 | share | Increase | +3.31% | 4.25K shares | 2.12M | $156.85 | 132.72K |
Q2 2016 | share | Increase | +5.19% | 6.33K shares | 1.68M | $145.56 | 128.46K |
Q1 2016 | share | Increase | +51.72% | 41.63K shares | 5.87M | $139.34 | 122.13K |